{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"submitter":["Takada N"],"funding":["Santen Pharmaceutical Co","Japan Agency for Medical Research and Development","Japan Science and Technology Agency","Japan Society for the Promotion of Science"],"pagination":["718"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC11940370"],"repository":["biostudies-literature"],"omics_type":["Unknown"],"volume":["13(3)"],"pubmed_abstract":["<b>Objectives:</b> The objective of this study was to identify novel autoantibodies specific for open-angle glaucoma (OAG), including normal-tension glaucoma (NTG) and primary open-angle glaucoma (POAG), using proteome-wide autoantibody screening and to determine their utility for diagnosis. <b>Methods:</b> We conducted proteome-wide autoantibody screening by wet protein arrays. Autoantibody reactivity in the plasma of OAG patients (50 NTG and 69 POAG patients) was quantitatively analyzed and compared to that of controls (35 cataract patients). The area under the curve (AUC) of the receiver operating characteristic (ROC) and multivariate analyses were used to determine diagnostic potential in patients with OAG. <b>Results:</b> Based on differences in autoantibody titers and positivity rate"],"journal":["Biomedicines"],"pubmed_title":["Proteome-Wide Analysis of Autoantibodies in Open-Angle Glaucoma in Japanese Population: A Pilot Study."],"pmcid":["PMC11940370"],"funding_grant_id":["JPMJPF2201","22K09827,HK 26462629,","none","JP17bm0404017, JP18hm0102029"],"pubmed_authors":["Izumi Y","Ishikawa M","Shintani C","Nakazawa T","Kunikata H","Osanai A","Goshima N","Ninomiya T","Tsusu C","Takada N","Hanyuda A","Fukuda E","Sato K","Yamaguchi K","Zorumski CF","Ono C","Kirihara T"],"additional_accession":[]},"is_claimable":false,"name":"Proteome-Wide Analysis of Autoantibodies in Open-Angle Glaucoma in Japanese Population: A Pilot Study.","description":"<b>Objectives:</b> The objective of this study was to identify novel autoantibodies specific for open-angle glaucoma (OAG), including normal-tension glaucoma (NTG) and primary open-angle glaucoma (POAG), using proteome-wide autoantibody screening and to determine their utility for diagnosis. <b>Methods:</b> We conducted proteome-wide autoantibody screening by wet protein arrays. Autoantibody reactivity in the plasma of OAG patients (50 NTG and 69 POAG patients) was quantitatively analyzed and compared to that of controls (35 cataract patients). The area under the curve (AUC) of the receiver operating characteristic (ROC) and multivariate analyses were used to determine diagnostic potential in patients with OAG. <b>Results:</b> Based on differences in autoantibody titers and positivity rate","dates":{"release":"2025-01-01T00:00:00Z","publication":"2025 Mar","modification":"2025-07-11T03:03:58.093Z","creation":"2025-07-11T03:03:58.093Z"},"accession":"S-EPMC11940370","cross_references":{"pubmed":["40149693"],"doi":["10.3390/biomedicines13030718"]}}